Did You Develop Breast Cancer After Taking Risperdal or Zyprexa?

Recent studies have established a potential link between the blockbuster antipsychotic drugs Risperdal and Zyprexa and an increased breast cancer risk. Lawsuits filed against manufacturers Johnson & Johnson and Eli Lilly allege that these companies knowingly concealed evidence of potential cancer risks linked to elevated prolactin levels while continuing to market their drugs for both approved and off-label uses.

Start My Antipsychotic Breast Cancer Lawsuit Claim Now

Name *

First

Last

Email *

Phone (we text, too) *

What happened? *

Checkboxes *

I Agree

Disclaimer: We may record your interactions with this website. I agree to receive marketing. By clicking Agree and Continue, you provide your electronic signature, express written consent and binding agreement to our Terms of Use, Privacy Policy, and CBW Law Terms and Conditions and Privacy Policy. You also agree to be contacted by CBW Law by email, call and/or text at the email address and telephone number you provided above, including possibly using an automatic telephone dialing system, prerecorded messages and artificial/A.I. voices, with case evaluations, legal marketing offers and other information, including outside of normal calling windows. Normal rates apply and consent is not a condition of purchase as you can always receive information by emailing us at [email protected]

Risperdal and Zyprexa Breast Cancer Lawsuits

Recent studies have established a potential link between the blockbuster antipsychotic drugs Risperdal and Zyprexa and an increased breast cancer risk. Lawsuits filed against manufacturers Johnson & Johnson and Eli Lilly allege that these companies knowingly concealed evidence of potential cancer risks linked to elevated prolactin levels while continuing to market their drugs for both approved and off-label uses.

The emergence of evidence indicating a potential link between Risperdal (risperidone) and Zyprexa (olanzapine) and an increased risk of breast cancer has raised significant concerns regarding the safety of these blockbuster antipsychotic medications. Legal claims against Johnson & Johnson and Eli Lilly allege that the drug manufacturers failed to adequately warn consumers about the potential risks associated with these drugs, particularly their link to breast cancer. If you or someone you love was diagnosed with breast cancer after using risperidone or olanzapine, call our consumer advocates or fill out the form on this page to be connected to an attorney with experience handling antipsychotic drug injury claims.

Alternatives to Risperdal and Zyprexa

According to data from the National Institute of Mental Health, approximately 59.3 million adults in the United States—representing 23.1% of the adult population—live with a mental illness, with young adults aged 18-25 experiencing the highest prevalence. These statistics underscore the critical need for safe and effective mental health treatment options.

For individuals seeking treatment for mental health conditions, there are alternatives to Risperdal and Zyprexa that may carry fewer risks of severe side effects, such as breast cancer. Patients should consult with their healthcare providers to determine the most appropriate treatment options based on their individual needs and medical history.

What is Risperdal?

Risperdal, generically known as risperidone, is an atypical antipsychotic medication primarily used to treat schizophrenia, bipolar disorder, and irritability associated with autism. Approved by the FDA in 1993, Risperdal works by altering the effects of neurotransmitters in the brain, particularly dopamine and serotonin.

Risperdal is manufactured by Janssen Pharmaceuticals, Inc., a subsidiary of pharmaceutical giant Johnson & Johnson. The medication functions by blocking dopamine receptors, which helps to stabilize mood and reduce symptoms of psychosis. However, this mechanism can also lead to increased levels of prolactin, a hormone that plays a crucial role in breast tissue development.

What is Zyprexa?

Zyprexa, or olanzapine, is another atypical antipsychotic that was approved by the FDA in 1996. It is commonly prescribed for similar conditions as Risperdal, including schizophrenia and bipolar disorder.

Zyprexa was originally manufactured by Eli Lilly and Company. However, Eli Lilly sold the rights to Zyprexa to Cheplapharm Arzneimittel GmbH in 2023. The medication works by blocking various neurotransmitter receptors, including dopamine and serotonin. This action helps to alleviate symptoms of mental health disorders, but can also lead to elevated prolactin levels, similar to Risperdal.

Potential Side Effects Leading to an Antipsychotic Injury Lawsuit

Both Risperdal and Zyprexa are associated with a range of alleged side effects, some of which can be severe. Notably, the potential for elevated prolactin levels from Risperdal or Zyprexa treatment can lead to significant health issues, including:

Hyperprolactinemia: This condition occurs when there is an excess of prolactin in the blood, which can lead to various complications, potentially including breast cancer.
Weight Gain: Both medications are known to cause significant weight gain, which can contribute to other health problems.
Metabolic Syndrome: Patients may experience changes in glucose and lipid metabolism, potentially increasing the risk of diabetes and cardiovascular disease.
Movement Disorders: Some patients may develop tardive dyskinesia or other movement-related side effects of Risperdal and Zyprexa.

These side effects have prompted legal action against the manufacturers, alleging that they failed to adequately warn consumers about the alleged risks associated with their medications.

Link Between Risperdal, Zyprexa, and Breast Cancer

Recent research has highlighted another serious potential side effect of Risperdal and Zyprexa: an increased risk of breast cancer. According to a 2024 study, “Breast cancer is more prevalent in women with severe mental illness than in the general population, and use of prolactin-increasing antipsychotics may be a contributing factor.” Evidence suggests that both Risperdal and Zyprexa can elevate prolactin levels in users, a potential risk associated with breast tissue development and breast cancer.

Lawsuits Alleging Antipsychotic Breast Cancer Injuries

April 2025 – The first lawsuit alleging a link between the antipsychotic drugs Risperdal and Zyprexa and an increased risk of breast cancer is filed in California Superior Court. The complaint seeks compensatory and punitive damages, alleging strict liability for failure to warn, fraud, and negligence.

Antipsychotic Breast Cancer Warnings From the FDA

January 2025 – The FDA expands the Risperdal safety information label to include information about the potential link between hyperprolactinemia (elevated prolactin levels) and breast cancer.

January 2025 – The FDA expands the Zyprexa safety information label to include information about the potential link between hyperprolactinemia (elevated prolactin levels) and breast cancer.

Antipsychotic Drug Breast Cancer Side Effect Studies

Why We Think J&J and Eli Lilly Should Be Held Liable for Alleged Breast Cancer Side Effects

The allegations against Johnson & Johnson and Eli Lilly center on the drug manufacturers’ alleged failure to adequately warn consumers about the potential risks associated with their blockbuster antipsychotic medications. The evidence suggests that both companies were aware of the potential dangers yet chose to prioritize profits over patient safety. Key arguments raised against J&J and Eli Lilly include:

Negligence: The companies allegedly failed to provide adequate warnings about the potential risks of breast cancer associated with their medications.
Concealment of Evidence: There is evidence suggesting that both companies were aware of studies linking their drugs to elevated prolactin levels and breast cancer, but chose not to disclose this information.
Marketing Practices: The aggressive marketing of these medications for off-label uses has contributed to widespread use among vulnerable populations, potentially increasing the risk of adverse effects.

These factors contribute to the argument that the manufacturers of Risperdal and Zyprexa should be held accountable for the alleged harm caused by their antipsychotic drug products.

Drug Lawsuits

Risperdal and Zyprexa Breast Cancer Lawsuits claim?

(800) 729-1232

Leading Justice
Fighting For The People

What should you do? If you took Risperdal or Zyprexa and developed breast cancer, you should contact a lawyer as soon as possible to discuss filing a product liability lawsuit.

Start Your Claim Now!

The number of lawsuits against Johnson & Johnson and Eli Lilly is expected to grow as more information comes to light about the potential safety risks of Risperdal and Zyprexa. As more evidence emerges potentially linking these medications to breast cancer, it is essential for patients to be informed and proactive in seeking justice for any harm allegedly caused by these drugs. If you or a loved one were diagnosed with breast cancer after taking Risperdal or Zyprexa, it is crucial to seek qualified legal guidance. You may be entitled to compensation for medical expenses, pain and suffering, and other damages related to your diagnosis. Call our consumer advocates today for help.

Call Today: (800) 729-1232